anisodamine has been researched along with No-Reflow Phenomenon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, M; Niu, X; Peng, Y; Sun, S; Zhang, J; Zhang, Z | 1 |
| Bing, R; Lowe, HC | 1 |
| Fu, X; Geng, W; Li, W; Peng, Y; Ru, L; Sun, J; Xing, K; Zhao, Y | 1 |
1 review(s) available for anisodamine and No-Reflow Phenomenon
| Article | Year |
|---|---|
Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Topics: Aged; Bayes Theorem; Coronary Circulation; Female; Humans; Male; Middle Aged; No-Reflow Phenomenon; Odds Ratio; Percutaneous Coronary Intervention; Risk Factors; Solanaceous Alkaloids; ST Elevation Myocardial Infarction; Treatment Outcome; Vasodilator Agents | 2018 |
1 trial(s) available for anisodamine and No-Reflow Phenomenon
| Article | Year |
|---|---|
Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; China; Coronary Angiography; Diltiazem; Drug Therapy, Combination; Female; Humans; Injections, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Prospective Studies; Solanaceous Alkaloids; Stents; Time Factors; Treatment Outcome; Vasodilator Agents | 2014 |
1 other study(ies) available for anisodamine and No-Reflow Phenomenon
| Article | Year |
|---|---|
No reflow in ST elevation myocardial infarction: a new way forward?
Topics: Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Diltiazem; Female; Humans; Male; Myocardial Infarction; No-Reflow Phenomenon; Solanaceous Alkaloids; Vasodilator Agents | 2014 |